Southwest Florida Cardiovascular Imaging Symposium 2024

1. Overview
The Southwest Florida Cardiovascular Imaging Symposium 2024 provides a comprehensive clinical update on the latest advancements and practical applications in cardiovascular imaging. The program focuses heavily on the growing capabilities of cardiac CT, the integration of artificial intelligence, and the use of advanced imaging biomarkers for risk assessment and structural heart interventions.
Course Date: 2024
2. Learning Objectives

Evaluate the expanding diagnostic capabilities of cardiac CT in the evaluation of arrhythmias, cardiomyopathies, and aortic stenosis.

Implement strategies to build and develop efficient cardiac CT programs and service lines within clinical practice.

Apply advanced imaging biomarkers, such as CT-derived plaque, pericoronary fat, and epicardial fat, to accurately assess cardiovascular risk.

Assess the role of CT, MRI, and PET imaging in the evaluation of cardiac masses and lesion-level ischemia.

Utilize advanced imaging techniques, including CT-guided 3D printing and pre-procedural planning, to optimize outcomes in structural heart interventions and LAA occlusion.

3. Target Audience

Best for cardiologists and radiologists who want advanced updates on cardiac CT applications, structural heart imaging, and imaging biomarkers.

4. Topics

01 Building Efficient Cardiac CT Programs – Panel Discussion

02 Developing a Cardiac CT Service Line

03 CT on Rhythm- Cardiac CT in Modern Evaluation of Arrhythmias

04 Diagnostic Capabilities of Cardiac CT in Cardiomyopathies

05 CT-Guided 3D Printing for Structural Heart Intervention

06 Cardiac Masses – What is the role of CT, CMR and PET

07 Harnessing Advanced Imaging Biomarkers – CT-derived Plaque and Pericoronary Fat

08 Cardiac CT in Guiding Surgical Interventions- Case Studies and Innovations

09 CT for Aortic Stenosis

10 CT Derived Lesion Level Ischemia

11 Cardiac MRI on the Heels of a CT Boom

12 AI in CT

13 Coronary CTA for Chronic Total Occlusion PCI

14 Role of CAC and CCTA in Assessing Cardiovascular Risk- Current Trends and Future Directions

15 The Role of CCTA in LAA Exclusion

16 The Argument for Trans-esophageal Echocardiography in LAA Occlusion

17 Perfusion, Functional CT and Future Advances of Cardiac CT

18 Evolving Role of Cardiac CT in Women’s Coronary Disease

19 Epicardial Fat – A Novel Marker of Cardiovascular Risk

20 Peri-procedural LAAO Evaluation – Ditch the Probe